Patent Ruling Imperils Another Merck Drug
230281
Merck received yet another blow when a court unexpectedly invalidated a patent on Fosamax, an osteoporosis treatment that is Merck's second-best-selling drug.
520589
Investors are discouraged after it releases the latest data for its top drug.
565054
NEW YORK - The state and city sued Merck &amp; Co. Inc. yesterday, saying the drug maker defrauded Medicaid and other government insurance programs by hiding the risks of heart problems associated with its pain medication Vioxx.
557
TRENTON, N.J. -- A federal court invalidated the patent yesterday for Merck &amp; Co.'s second-largest-selling drug, the blockbuster osteoporosis treatment Fosamax, in a decision that offers millions of patients hope for a cheaper version sooner, but darkens the company's already clouded outlook.
226791
A court ruling upholding the  patent on blockbuster blood-thinning drug Plavix has reignited  talk France&#39;s Sanofi-Aventis  will bid for its smaller  U.S. partner Bristol-Myers Squibb Co. .
496294
The withdrawal of Merck &amp; Co. Inc.&#39;s arthritis drug Vioxx will make it harder for drug companies to win approval for products aimed at big patient populations as regulators
113552
TORONTO (CP) - A Toronto-based law firm filed another class-action lawsuit Friday against drug maker Merck and Co. Inc., the makers of the arthritis drug Vioxx.
519863
The company faces a pivotal clinical trial.
81161
Drug giant Merck pulled its painkiller Vioxx because it increased the risk of heart attacks and strokes. Now the company may face thousands of lawsuits.
210917
A U.S. judge on Tuesday ruled that the patent on the multibillion-dollar blood clot-preventing drug Plavix is valid, handing a major victory to Bristol-Myers Squibb Co.  and Sanofi-Aventis .
741022
A federal jury ruled in favor of Merck &amp; Co. Inc. on Tuesday in a lawsuit over the painkiller Vioxx, finding there was not enough evidence to link the drug to a Kentucky man's heart attack.
459566
LONDON/NEW YORK  - A court ruling upholding the patent on blockbuster blood-thinning drug Plavix has reignited talk France's Sanofi-Aventis  will bid for its smaller U.S. partner Bristol-Myers Squibb Co. .
70993
BIRMINGHAM, Alabama  - Merck & Co. scored its second swift victory this week in a Vioxx product liability trial when an Alabama jury found on Friday it did not hide health risks associated with its withdrawn arthritis drug or knowingly market a faulty product.
45408
What a mess. Weeks after Merck &amp; Co. (MRK ) yanked its blockbuster painkiller Vioxx off the market, the furor is still raging.
316389
MERCK faces a fresh barrage of lawsuits over its Vioxx arthritis drug that together could cost it as much as $18 billion (Â£9.8 billion) as hundreds of lawyers from across America will next week team up for a combined attack on the embattled drug
236746
A month after Merck quit selling Vioxx in the face of new evidence that its blockbuster painkiller caused heart attacks, strokes and other serious ailments, the company and plaintiffsâ lawyers are scrambling to adjust to a surge in related lawsuits.
724710
A federal judge in New Orleans has thrown out a court victory for Merck & Co. , allowing a new, third trial for a widow who claims the company's blockbuster painkiller Vioxx caused her husband's fatal heart attack.